|
End-of-day quote
Shanghai S.E.
03/09/2026
|
5-day change | 1st Jan Change | ||
| 6.680 CNY | -1.76% |
|
-6.83% | +2.93% |
| Market Cap | 4.62B 689M 591M 555M 508M 949M 65.09B 957M 6.56B 2.55B 33.29B 2.59B 2.53B 107B | P/E 2024 |
18.1x | P/E 2025 | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.84B 572M 491M 461M 422M 788M 54.04B 794M 5.44B 2.12B 27.64B 2.15B 2.1B 89.13B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.65x |
| Free-Float |
79.74% | Yield 2024 |
4.93% | Yield 2025 | 5.39% |
| 1 day | -1.76% | ||
| 1 week | -6.83% | ||
| Current month | -6.18% | ||
| 1 month | +3.25% | ||
| 3 months | +4.70% | ||
| 6 months | +0.30% | ||
| Current year | +2.93% |
| 1 week | 6.67 |  | 7.33 |
| 1 month | 6.57 | | 7.45 |
| Current year | 5.6 | | 7.45 |
| 1 year | 5.6 | | 7.45 |
| 3 years | 4.94 | | 9 |
| 5 years | 4.94 | | 11.9 |
| 10 years | 4.5 | | 11.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 42 | 23/04/2019 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 54 | 17/05/2017 |
Peng Bo Ren
PRN | Corporate Officer/Principal | 53 | 11/03/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Wu Xian Ren
CHM | Chairman | 66 | 26/05/2005 |
Peng Bo Ren
BRD | Director/Board Member | 53 | 15/05/2014 |
Wei Ren
BRD | Director/Board Member | 42 | 23/04/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.76% | -6.83% | -4.84% | -14.03% | 700M | |
| -0.81% | +0.87% | +22.41% | +72.77% | 49.06B | |
| +0.41% | +0.12% | +52.20% | +121.38% | 40.37B | |
| -0.97% | -0.61% | +14.75% | +86.17% | 12.19B | |
| -1.28% | -0.57% | -11.12% | +11.99% | 12.08B | |
| +0.57% | +0.95% | +29.02% | +153.11% | 9.14B | |
| +0.08% | -3.68% | +23.29% | +42.89% | 7.36B | |
| -0.04% | +0.85% | +28.15% | +224.81% | 7.35B | |
| +0.81% | -0.04% | +45.87% | -10.06% | 7.32B | |
| +0.03% | -1.75% | -40.80% | +14.39% | 5.19B | |
| Average | -0.30% | -1.06% | +15.89% | +70.34% | 15.08B | |
| Weighted average by Cap. | -0.27% | +0.33% | +26.64% | +86.39% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.69B 400M 344M 323M 295M 551M 37.82B 556M 3.81B 1.48B 19.35B 1.5B 1.47B 62.37B | 2.24B 334M 287M 269M 246M 460M 31.54B 464M 3.18B 1.24B 16.13B 1.25B 1.23B 52.02B |
| Net income | 243M 36.17M 31.05M 29.14M 26.69M 49.8M 3.42B 50.24M 344M 134M 1.75B 136M 133M 5.64B | 320M 47.69M 40.94M 38.43M 35.19M 65.67M 4.51B 66.24M 454M 177M 2.3B 179M 175M 7.43B |
| Net Debt | -483M -71.97M -61.78M -57.98M -53.1M -99.1M -6.8B -99.96M -685M -267M -3.48B -270M -264M -11.21B | -784M -117M -100M -94.18M -86.25M -161M -11.04B -162M -1.11B -433M -5.65B -439M -429M -18.21B |
Employees
3,415
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | CN¥6.680 | -1.76% | 16,638,669 |
| 02/09/26 | CN¥6.800 | -3.00% | 21,687,105 |
| 01/09/26 | CN¥7.010 | -1.54% | 28,838,591 |
| 31/08/26 | CN¥7.120 | -2.06% | 28,041,471 |
| 28/08/26 | CN¥7.270 | +0.97% | 25,712,947 |
- Stock Market
- Stocks
- 600351 Stock
Select your edition
All financial news and data tailored to specific country editions
